GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mitesco Inc (OTCPK:MITI) » Definitions » 5-Year RORE %

Mitesco (Mitesco) 5-Year RORE % : -6.14% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Mitesco 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Mitesco's 5-Year RORE % for the quarter that ended in Dec. 2023 was -6.14%.

The industry rank for Mitesco's 5-Year RORE % or its related term are showing as below:

MITI's 5-Year RORE % is ranked worse than
64.19% of 430 companies
in the Healthcare Providers & Services industry
Industry Median: 4.43 vs MITI: -6.14

Mitesco 5-Year RORE % Historical Data

The historical data trend for Mitesco's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mitesco 5-Year RORE % Chart

Mitesco Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -50.14 -55.19 0.88 16.14 -6.14

Mitesco Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.14 12.06 15.01 9.79 -6.14

Competitive Comparison of Mitesco's 5-Year RORE %

For the Health Information Services subindustry, Mitesco's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mitesco's 5-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mitesco's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Mitesco's 5-Year RORE % falls into.



Mitesco 5-Year RORE % Calculation

Mitesco's 5-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -2.987--4.009 )/( -16.644-0 )
=1.022/-16.644
=-6.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 5-year before.


Mitesco  (OTCPK:MITI) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Mitesco 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Mitesco's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mitesco (Mitesco) Business Description

Traded in Other Exchanges
N/A
Address
18202 Minnetonka Boulevard, Suite 100, Deephaven, MN, USA, 55391
Mitesco Inc is a development stage company who acquires and implements technologies and services to improve the quality of care, reduce cost, and enhance consumer convenience. It is focused on developing a portfolio of companies that provide healthcare technology solutions and the team is adept at deal structures supportive of long term organizational value.
Executives
Lonnie Allen Plunk director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Lawrence M. Diamond director 7535 EAST HAMPDEN AVENUE, SUITE 400, DENVER CO 80231
Phillip J Keller officer: Chief Financial Officer 2323 RING ROAD, ELIZABETHTOWN KY 42701
Sheila Schweitzer director 1200 CAROLINA CIRCLE, VERO BEACH FL 62962
Ingrid Jenny Lindstrom officer: Chief Legal Officer 1100 WILLS PLACE, GOLDEN VALLEY MN 55422
Juan Carlos Iturregui director 5606 ALBIA RD., BETHESDA MD 20816
Faraz Naqvi director 3001 HEARTHSTONE DRIVE, FORT COLLINS CO 80528
Thomas Brodmerkel director 7535 EAST HAMPDEN AVENUE, STE. 400, DENVER CO 80231
Julie R. Smith director 7535 EAST HAMPDEN AVENUE, SUITE 400, DENVER CO 80231
Ron Riewold officer: CHAIRMAN 37 NORTH ORANGE AVE, STE 500, ORLANDO FL 32801
Douglas Cole director C/O AMERICAN BATTERY METALS CORP, 930 TAHOE BLVD, STE 802-16, INCLINE VILLAGE NV 89451
James Philip Crone director, officer: Pres, Interim CFO, Sec, Dir 1355 PEACHTREE STREET, SUITE 1150, ATLANTA GA 30309
Morton James E Iii officer: President 549 VIKINGS LANE, ATLANTIC BEACH FL 32233
Deluca Louis George Jr officer: C.O.O. 194 EDWARDS DR, MABLETON GA 30126
Thomas W. Burnell officer: President and CEO 1355 PEACHTREE STREET, SUITE 1150, ATLANTA GA 30309